Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jan 3, 2019 at 1:15 PM EST

Catabasis Gears Up for Late-Stage Duchenne Muscular Dystrophy Trial

Catabasis shares jumped on Thursday after the company provided an update from its late-stage trial for edasalonexent in Duchenne muscular…

Chris Lange | Jan 3, 2019 at 11:40 AM EST

Big Changes Coming at Atara Biotherapeutics

Atara Biotherapeutics shares dipped on Thursday after the company provided a few business updates.

Chris Lange | Jan 3, 2019 at 10:50 AM EST

Are Sesen Bio’s Bladder Cancer Preliminary Results Good Enough?

Sesen Bio shares took a beating on Thursday despite posting positive data for its late-stage trial for patients with high-grade…

Chris Lange | Jan 3, 2019 at 9:50 AM EST

Why DBV Technologies Is Changing Up Senior Leadership

DBV Technologies shares made a handy gain on Thursday after the company announced that it would be making some changes…

Paul Ausick | Jan 3, 2019 at 8:50 AM EST

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene…

Chris Lange | Jan 3, 2019 at 8:45 AM EST

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series…

Douglas A. McIntyre | Jan 3, 2019 at 5:34 AM EST

Girl Scouts Release Gluten-Free Cookies

Girl Scout Cookies have been sold since 1917. Among the many flavors and shapes, there has never been a gluten-free…

Jon C. Ogg | Jan 2, 2019 at 2:00 PM EST

Why Value Investors May Flock to Top Biotechs in 2019

Here is a review of the outlook and expectations for 2019 in seven top biotechs valued at $20 billion or…

Jon C. Ogg | Jan 2, 2019 at 11:45 AM EST

How Paratek Could Rise 170% Due to Strong Infectious Disease Treatment Expectations

Could this small clinical-stage emerging pharmaceuticals outfit have upside of almost 200%? That's what one firm has said on the…

Chris Lange | Jan 2, 2019 at 10:40 AM EST

Why Cara Therapeutics Is One of Wednesday’s Big Winners

Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial.

Chris Lange | Jan 2, 2019 at 9:05 AM EST

TCR2 Therapeutics Files for IPO

Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.

Chris Lange | Dec 28, 2018 at 9:45 AM EST

Opko Settles Fraud Charges With SEC: Good News for Investors?

Opko Health shares shot up on Friday after the firm announced that it has settled with the SEC with regard…

Chris Lange | Dec 28, 2018 at 8:40 AM EST

Harpoon Therapeutics Files for IPO

Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering.

Chris Lange | Dec 27, 2018 at 11:40 AM EST

Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?

Spectrum Pharma shares dipped on Thursday after the firm announced a key update from the FDA on its treatment of…

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 109 110 111 112 113 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Catabasis Gears Up for Late-Stage Duchenne Muscular Dystrophy Trial

Big Changes Coming at Atara Biotherapeutics

Are Sesen Bio’s Bladder Cancer Preliminary Results Good Enough?

Why DBV Technologies Is Changing Up Senior Leadership

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Girl Scouts Release Gluten-Free Cookies

Why Value Investors May Flock to Top Biotechs in 2019

How Paratek Could Rise 170% Due to Strong Infectious Disease Treatment Expectations

Why Cara Therapeutics Is One of Wednesday’s Big Winners

TCR2 Therapeutics Files for IPO

Opko Settles Fraud Charges With SEC: Good News for Investors?

Harpoon Therapeutics Files for IPO

Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?

Short Sellers Hike Bets in Major Pharma Stocks

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

AMD Sinks 6% Despite a Holding Pattern in Intel and NVIDIA: The Selective AI Chip Trade Is Here

XRP Price: Will XRP’s Cup-and-Handle Breakout Finally Confirm This Week?

Wall Street Sees 21% Upside for Rivian Despite R2 Pricing Disappointment

I Have $7.5 Million in a Traditional IRA at 60 — How Aggressively Should I Do Roth Conversions?

The 143% Wealth Gain Under 35 Masks a Harsh Reality: $370,000 Behind the Oldest Americans

Andrew Sather Says Companies Are Getting “Creative” With Stock Dilution. Here’s How to Spot When It’s Quietly Costing You

AMD Sinks 6% Despite a Holding Pattern in Intel and NVIDIA: The Selective AI Chip Trade Is Here

Health and Healthcare Articles

All Health and Healthcare Articles

Catabasis Gears Up for Late-Stage Duchenne Muscular Dystrophy Trial

Big Changes Coming at Atara Biotherapeutics

Are Sesen Bio’s Bladder Cancer Preliminary Results Good Enough?

Why DBV Technologies Is Changing Up Senior Leadership

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Girl Scouts Release Gluten-Free Cookies

Why Value Investors May Flock to Top Biotechs in 2019

How Paratek Could Rise 170% Due to Strong Infectious Disease Treatment Expectations

Why Cara Therapeutics Is One of Wednesday’s Big Winners

TCR2 Therapeutics Files for IPO

Opko Settles Fraud Charges With SEC: Good News for Investors?

Harpoon Therapeutics Files for IPO

Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?

Short Sellers Hike Bets in Major Pharma Stocks

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

AMD Sinks 6% Despite a Holding Pattern in Intel and NVIDIA: The Selective AI Chip Trade Is Here

XRP Price: Will XRP’s Cup-and-Handle Breakout Finally Confirm This Week?

Wall Street Sees 21% Upside for Rivian Despite R2 Pricing Disappointment

Featured Reads

I Have $7.5 Million in a Traditional IRA at 60 — How Aggressively Should I Do Roth Conversions?

The 143% Wealth Gain Under 35 Masks a Harsh Reality: $370,000 Behind the Oldest Americans